Former Pharma Employees Booked for Alleged Rs 1 Crore Extortion, Forging Documents

Written By :  Susmita Roy
Published On 2026-05-01 07:30 GMT   |   Update On 2026-05-01 07:30 GMT
Advertisement

New Delhi: The Delhi Police Crime Branch has registered a case following a complaint by a pharmaceutical company alleging that two of its former employees created a fake sister concern and fraudulently secured government tenders using forged documents.

According to the recent media report in The Times of India, the accusation include the use of fabricated company letterheads submitted to the Ministry of Defence. These documents were later found to be fake during verification, leading to the cancellation of the tender and blacklisting of the firm involved.

According to the complaint, one of the accused had previously worked with the company and had access to highly confidential business information. He, along with another former employee, was allegedly involved in misappropriating company funds before being terminated in 2023.

One India reports that the FIR in the case was registered on April 18 based on a complaint filed by a representative of SMPL Life Sciences Private Limited, a firm based in Janakpuri, Delhi. The accused have been identified as Prabhnoor Singh Puri from Paschim Vihar and Ajay Kumar from Janakpuri.

The complaint states that both individuals, during their tenure, had access to sensitive data including client databases, pricing details, tender documents, and financial records. After their dismissal, they allegedly used this information to establish a separate entity named Mammoth Life Sciences LLP, reportedly operating from the Mayapuri industrial area.

Police allege that the accused falsely presented their new firm as a sister concern of the original company and used forged documents to secure government contracts, including those related to medicine supplies for Army hospitals. The complaint further claims that fake letterheads were submitted in processes linked to the Ministry of Defence, which were later disowned by the concerned pharmaceutical company upon verification.

The alleged fraud came to light during scrutiny by the Army’s Research and Referral (R&R) Hospital, which flagged irregularities in procurement and drug supply records. Following this, authorities reportedly cancelled the tender, blacklisted the entity, and drug regulators are said to have barred the firm and revoked its licence, reports TOI.

The FIR also includes serious allegations of extortion and criminal intimidation. The complainant has claimed that the accused demanded ₹1 crore and threatened to leak confidential data and cause physical harm. It was also alleged that they attempted to damage the company’s reputation by making false claims to clients and officials, and even cited links with organised crime syndicates.

Delhi Police have stated that the investigation is ongoing. Officials are examining procurement procedures, authenticity of documents, and supply records, and further action will be taken based on findings from evidence and witness statements.

Tags:    
Article Source : With inputs

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News